The National Association of Medicaid Directors released a public memo which discusses average acquisition cost (AAC) methodologies for Medicaid prescription drug reimbursement. The memo also provides an update on CMS’s progress finalizing average market price-based Federal Upper Limits (AMP-based FULs) for prescription drugs.
- This week the NAMD newsletter welcomes new directors and covers LTSS, national health expenditures, Hill news on CHIP and tax reform, value based purchasing and Medicaid leadership. December 12, 2017
- In the newsletter we cover Opioids, Access Rule guidance, Medicare Part D, NASBO expenditure report and state job opportunities. November 28, 2017
- NAMD newsletter covers our Fall Conference; 1115 waivers; CHIP; Opioids; and State job openings. November 14, 2017